Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis.
Using a highly abbreviated California Verbal Learning Test-II to detect verbal memory deficits.
Capture, crawl, cross: the T cell code to breach the blood-brain barriers.
Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations.
Demyelinating Diseases: Myeloperoxidase as an Imaging Biomarker and Therapeutic Target.
Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
Tremor reduction and quality of life after deep brain stimulation for multiple sclerosis-associated tremor.
The anti-IL-17A antibody secukinumab does not attenuate ozone-induced airway neutrophilia in healthy volunteers.
Brain Region-specific Alterations in the Gene Expression of Cytokines, Immune Cell Markers and Cholinergic System Components During Peripheral Endotoxin-induced Inflammation.
[Cognitive performance and quality of life in multiple sclerosis in Gipuzkoa].
Autonomic dysfunction: A unifying multiple sclerosis theory, linking chronic cerebrospinal venous insufficiency, vitamin D(3), and Epstein-Barr virus.
Relationships Between Retinal Axonal and Neuronal Measures and Global Central Nervous System Pathology in Multiple Sclerosis.
Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination.
FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ(42))-Induced Impairment of Spatial Learning and Memory in Rats.
The role of tumour necrosis factor α in the pathogenesis of multiple sclerosis, and pentoxifylline as a possible pharmacotherapeutic intervention.
The histaminergic network in the brain: basic organization and role in disease.
Kappa free light chains: diagnostic and prognostic relevance in MS and CIS.
Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations.
European ancestry predominates in neuromyelitis optica and multiple sclerosis patients from Brazil.
CCSVI and MS: a statement from the European Society of neurosonology and cerebral hemodynamics.
Humoral immune response to influenza vaccine in natalizumab-treated MS patients.
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.
Epitope-specific immune tolerization ameliorates experimental autoimmune encephalomyelitis.
SymptoMScreen: A Tool for Rapid Assessment of Symptom Severity in MS Across Multiple Domains.
The autonomic balance predicts cardiac responses after the first dose of fingolimod.
Pages
« first
‹ previous
…
185
186
187
188
189
190
191
192
193
…
next ›
last »